The store will not work correctly when cookies are disabled.
(E)-4-(3-(3-(4-fluorophenyl)acryloyl)-2-oxoimidazolidine-1-carbonyl)benzonitrile
ID: ALA4745627
PubChem CID: 162648175
Max Phase: Preclinical
Molecular Formula: C20H14FN3O3
Molecular Weight: 363.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(C(=O)N2CCN(C(=O)/C=C/c3ccc(F)cc3)C2=O)cc1
Standard InChI: InChI=1S/C20H14FN3O3/c21-17-8-3-14(4-9-17)5-10-18(25)23-11-12-24(20(23)27)19(26)16-6-1-15(13-22)2-7-16/h1-10H,11-12H2/b10-5+
Standard InChI Key: MGFBFBHGEUZTBV-BJMVGYQFSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
28.4839 -26.2381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5823 -25.4047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5812 -26.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2960 -26.6449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0125 -26.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0096 -25.4010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2942 -24.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7225 -24.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4386 -25.3956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1515 -24.9804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8675 -25.3902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.1484 -24.1554 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9592 -26.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7669 -26.3782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1767 -25.6621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6223 -25.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7909 -24.2436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9968 -25.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3295 -24.8178 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8664 -26.6439 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.1483 -26.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6346 -27.6572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4552 -27.5684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7871 -26.8090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2988 -26.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9460 -28.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4342 -28.8951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 11 1 0
16 17 2 0
15 18 1 0
18 1 1 0
18 19 2 0
3 20 1 0
1 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 1 1 0
26 27 3 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.35 | Molecular Weight (Monoisotopic): 363.1019 | AlogP: 2.82 | #Rotatable Bonds: 3 |
Polar Surface Area: 81.48 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.10 | CX LogD: 3.10 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.79 | Np Likeness Score: -1.15 |
References
1. Ji L,Qu L,Wang C,Peng W,Li S,Yang H,Luo H,Yin F,Lu D,Liu X,Kong L,Wang X. (2021) Identification and optimization of piperlongumine analogues as potential antioxidant and anti-inflammatory agents via activation of Nrf2., 210 [PMID:33148493] [10.1016/j.ejmech.2020.112965] |